Ranexa and Furosemide drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Ranexa (ranolazine) and Furosemide (furosemide). Common drug interactions include pain among females and chronic kidney disease among males.
The phase IV clinical study analyzes what interactions people have when they take Ranexa and Furosemide. It is created by eHealthMe based on reports of 1,206 people who take the same drugs from the FDA, and is updated regularly.
What is Ranexa?
Ranexa has active ingredients of ranolazine. It is often used in angina. eHealthMe is studying from 11,758 Ranexa users. Check the latest studies of Ranexa.
What is Furosemide?
Furosemide has active ingredients of furosemide. It is often used in fluid retention. eHealthMe is studying from 316,095 Furosemide users. Check the latest studies of Furosemide.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
1,206 people who take Ranexa and Furosemide together, and have interactions are studied.
What are the common drug interactions of Ranexa and Furosemide, by gender? *
What are the common drug interactions of Ranexa and Furosemide, by age (0-1 to 60+)? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Ranexa and Furosemide?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Ranexa (11,758 reports)
- Furosemide (316,095 reports)
Browse all drug interactions of Ranexa and Furosemide:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Ranexa:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Furosemide:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Ranexa and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Furosemide and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Ochoa PS, Fisher T, "A 7‐Year Case of Furosemide‐Induced Immune Thrombocytopenia", Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2013 Jul .
- Ochoa PS, Fisher T, "A 7‐Year Case of Furosemide‐Induced Immune Thrombocytopenia", Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2013 Jul .
How the study uses the data?
The study uses data from the FDA. It is based on ranolazine and furosemide (the active ingredients of Ranexa and Furosemide, respectively), and Ranexa and Furosemide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Keflex and Systemic Lupus Erythematosus for Women aged 50-59 - 7 seconds ago
- Keflex and Sle for Women aged 50-59 - 7 seconds ago
- Keflex and Lupus for Women aged 50-59 - 7 seconds ago
- Keflex and Disseminated Lupus Erythematosus for Women aged 50-59 - 8 seconds ago
- Keflex and Lupus Erythematosus for Women aged 50-59 - 8 seconds ago
- Could Norvasc cause Generalized Anxiety Disorder? - 11 seconds ago
- Drug interactions of Fludrocortisone Acetate and Aspirin - 16 seconds ago
- Fentanyl vs. Hydroxyzine Pamoate, side effect and effectiveness comparison - 21 seconds ago
- Dry Skin and drugs of ingredients of umeclidinium bromide - 22 seconds ago
- Drug interactions of Entecavir and Tacrolimus - 37 seconds ago